September 21, 2026
Business

Piramal Pharma points to early recovery signs after seeing red in Q3(Soban News)

The company posted its results for the third quarter of FY26 late on Wednesday evening, with its revenue dipping 3% year-on-year to ₹2,140 crore, and slipping to a loss of ₹136 crore from a net profit of ₹4 crore in Q3FY25. Its ebitda margin shrank from 16% in Q3FY25 to 11% this fiscal.

​The company posted its results for the third quarter of FY26 late on Wednesday evening, with its revenue dipping 3% year-on-year to ₹2,140 crore, and slipping to a loss of ₹136 crore from a net profit of ₹4 crore in Q3FY25. Its ebitda margin shrank from 16% in Q3FY25 to 11% this fiscal. by Soban News (international And National News)

Related posts

Nifty IT hits fresh 52-week low as Infosys, TCS, Wipro & others tumble up to 3%. What’s spooking investors?(Soban News)

News-Soban-Admin

NASA spots hidden bubble in 2,000-year-old supernova—scientists say it’s “bouncing back” – Moneycontrol.com(Soban News)

News-Soban-Admin

Govt bond yields rise to five-month high ahead of large SDL supply

News-Soban-Admin

Leave a Comment